A study by researchers at the University of Birmingham has revealed how a novel type of water treatment for the brains of patients with dementia could be used to help prevent dementia.

The research is the first to show how a water treatment could reduce dementia in the brain, and suggests it could be a promising way to prevent the disease in the long term.

The study, which was published in the journal Lancet, looked at patients who had had a stroke or had a brain tumour.

They then used a water-based treatment which was applied to their brains, to try and reduce the amount of calcium that the body produces in the blood.

A more common treatment for this is a beta-blocker, which blocks calcium and keeps the brain’s calcium levels down.

The beta-blocking beta-agonists, such as Amilor, are commonly used to treat stroke and are a very effective treatment.

They are safe and effective for patients, and are commonly prescribed for stroke.

The researchers, led by Dr Simon Hallett, said that their research found the beta-blocks could be useful in preventing dementia, and in particular Alzheimer’s disease.

Dr Hallet said: “There are a lot of new treatment options available for people with dementia, which are used by the NHS, the doctors, the nursing staff.”

The way that these treatments work is they put a gel on top of the brain which gets injected into the brain and then when it is removed, it’s replaced with fresh water, which is a natural way of removing calcium from the brain.

“This is what happens in a patient’s brain Dr Hallelltt said that water treatment was a new type of treatment for dementia that could reduce Alzheimer’s by as much as 20%.

The researchers found that they could reduce brain calcium levels by 50% by using beta-Blockers.

What is beta- Blockers?

Beta-blockers are a type of calcium-modulating drug that can slow down the process of calcium release in the body.

This was shown in the study. “

We found that beta- blockers work as a beta blocker and prevent calcium loss from the blood, which then makes the brain less vulnerable to Alzheimer’s and stroke,” said Dr Hulett.

This was shown in the study.

Dr Hellett said: “It was very interesting to find that using beta blockers was a very strong way to reduce dementia.”

“What was interesting is that this was also a very safe and well-tolerated treatment for people, and that’s really important in a clinical setting.”

In the study, researchers found the treatment could prevent dementia by as little as 20% in patients with Alzheimer’s.

They also showed that beta blockers were safe and efficacious, and showed a significant reduction in the risk for developing dementia in older people compared to a placebo.

In some other studies, beta blockers have been used in combination with drugs that affect calcium levels, such the beta blockers used to control hypertension.

This is known as a calcium-sensing drug.

It has been found to reduce the symptoms of Alzheimer’s in some older patients.

However, Dr Hasellt said that beta blocker treatments had been a challenge to use in the UK, due to the difficulty in finding patients with existing symptoms.

He said:”There are also many problems with prescribing them, for example patients are too frail and need medication.”

We also have concerns about the side-effects, and there are a few issues around the cost.

“These are the challenges that we face when trying to find people who have Alzheimer’s.”

Dr Simon Halkett said: “I am excited about the new research, because it demonstrates that beta blockers are an effective treatment that can reduce the rate of dementia in people with Alzheimer and Parkinson’s disease, and help reduce the number of people with the disease.” 

Dr Halsett added:  “There’s still a lot we don’t know about beta blockers, so it’s very exciting that we now know more about them than we did a couple of years ago.”

A spokesperson for NHS England said:  “The NHS is working hard to improve the care of people who are suffering from dementia, as well as to tackle other challenges like obesity, hypertension, diabetes, stroke and anxiety.”

It is very important that the NHS continues to develop effective treatments and research into new therapies, so that we can keep people with these disorders out of hospital.

“More and more people are using beta blocker drugs to help reduce their symptoms, which can help keep people well, but more research is needed.”

The National Institute for Health Research said:   “This research was conducted in collaboration with the Department